Delivery Order SPE2DB22D3301-SPE2DB24FY8UT
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $2,154.12, provides the Defense Logistics Agency (DLA) with Lyrica 100 mg capsules. The contract is a firm-fixed price delivery order, with a completion date of June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 2025. This single-award IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) on August 9, 2024. The $3,497.90 firm fixed-price delivery order is for Lyrica 75 mg capsules, a prescription medication used to treat certain types of nerve pain. The contract has an ultimate completion date of August 12, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,454.21 firm fixed price delivery order is for the supply of Lyrica 75 mg capsules, a brand name prescription medication. The contract has a performance period that runs through March 6, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA worth up to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,177.02 and is for the delivery of Lyrica 25 mg capsules. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside award. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical as a firm fixed price delivery order for the supply of 100 mg Lyrica capsules. The contract has a potential value of $2,397.92 and a performance period through February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA), a defense agency, to provide Lyrica 25 mg capsules. The contract has a firm fixed price of $1,845.07 and a completion date of April 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lyrica 75 mg capsules. The $12,389.87 order has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4,562,300 units of Lyrica 50 mg capsules. The $3,458.71 firm fixed-price delivery order has a completion date of September 26, 2023 and is not associated with any set-aside requirements. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lyrica 50 mg capsules. The $1,626.00 contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with the Defense Logistics Agency with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $9,169.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Lyrica 50 mg capsules. Amerisourcebergen Drug Corp is the prime contractor, and the contract has an ultimate completion date of March 12, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp,...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY8UTDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lyrica 75 mg capsules in 90-count bottles. The contract, valued at $1,669.62, was awarded on June 17, 2024 by the Defense Logistics Agency (DLA), with a completion date of June 18, 2024. The contract is a firm-fixed price delivery order, without a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/17/24 |